Skip to main content
Shahin Rafii, MD, Hematology, New York, NY

Shahin Rafii MD

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology, Sickle Cell & Other Anemias


Arthur B Belfer Professor of Genetic Medicine, Division Chief of Regenerative Medicine, Department of Medicine, Director Ansary Stem Cell Institute; Professor of Reproductive Medicine, Weill Cornell Medicine, New York, NY, Founder: Angiocrine Bioscience, San Diego, CA

Join to View Full Profile
  • 1300 York AveWeill Cornell Medical College, Room A-863New York, NY 10065

  • Phone+1 917-287-3801

  • Fax+1 212-746-8481

Dr. Rafii is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1989 - 1992
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1986 - 1988
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 1986

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1987 - 2015

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2001
  • Investigator Howard Hughes Medical Institute

Publications & Presentations

PubMed

Journal Articles

  • Catheter-Directed Intraportal Delivery of Endothelial Cell Therapy for Liver Regeneration: A Feasibility Study in a Large-Animal Model of Cirrhosis  
    Kyungmouk Steve Lee, Shahin Rafii, David C. Madoff, David Li, Radiology

Abstracts/Posters

  • Integrated Single Cell Transcriptomics Defines an Engineered Niche Supporting Hematopoietic Stem Cell Development Ex Vivo
    Shahin Rafii, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Transcription Factor Induction of Ectopic Vascular Blood Stem Cell Niches In Vivo
    Shahin Rafii, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Fli-1 Transcriptionally Integrates Microenvironmental Cues Sensing By Self-Renewing Hematopoietic Stem and Progenitor Cells
    Shahin Rafii, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Reprogrammed Adult Human Endothelium into Hematopoietic Stem Cells Yields Functional T Cells In Vivo 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • ‘Flipping’ Switch Boosts Stem Cell Numbers for Therapies
    ‘Flipping’ Switch Boosts Stem Cell Numbers for TherapiesMarch 12th, 2025
  • FLIpping the Switch: Boosting Stem Cell Numbers for Therapies
    FLIpping the Switch: Boosting Stem Cell Numbers for TherapiesMarch 10th, 2025
  • Revolutionizing Type 1 Diabetes: Breakthrough in Islet Transplantation with Blood Vessel Cells Offers New Hope
    Revolutionizing Type 1 Diabetes: Breakthrough in Islet Transplantation with Blood Vessel Cells Offers New HopeFebruary 22nd, 2025
  • Join now to see all

Grant Support

  • Abnormal Extracellular Vesicles and Particles from Human Islets Impact T1D progressionWEILL MEDICAL COLL OF CORNELL UNIV2023–2028
  • Abnormal Extracellular Vesicles and Particles from Human Islets Impact T1D progressionWEILL MEDICAL COLL OF CORNELL UNIV2023–2028
  • Molecular Determinants of liver sinusoidal endothelial cells for hepatic regenerationWEILL MEDICAL COLL OF CORNELL UNIV2023–2028
  • Abnormal Extracellular Vesicles and Particles from Human Islets Impact T1D progressionWEILL MEDICAL COLL OF CORNELL UNIV2023–2028
  • Abnormal Extracellular Vesicles and Particles from Human Islets Impact T1D progressionWEILL MEDICAL COLL OF CORNELL UNIV2023–2028
  • Abnormal Extracellular Vesicles and Particles from Human Islets Impact T1D progressionWEILL MEDICAL COLL OF CORNELL UNIV2023–2028
  • Abnormal Extracellular Vesicles and Particles from Human Islets Impact T1D progressionWEILL MEDICAL COLL OF CORNELL UNIV2023–2028
  • Adaptable tissue-specific endothelial cells for organ regenerationWEILL MEDICAL COLL OF CORNELL UNIV2020–2027
  • Engineering islet-like organoids from gastric stem cells for T1D cell replacement therapyWEILL MEDICAL COLL OF CORNELL UNIV2022–2026
  • Derivation of pancreatic islet-like organoids from human gastric stem cellsWEILL MEDICAL COLL OF CORNELL UNIV2022–2026
  • Engineering islet-like organoids from gastric stem cells for T1D cell replacement therapyWEILL MEDICAL COLL OF CORNELL UNIV2022–2026
  • Derivation of pancreatic islet-like organoids from human gastric stem cellsWEILL MEDICAL COLL OF CORNELL UNIV2022–2026
  • Derivation of pancreatic islet-like organoids from human gastric stem cellsWEILL MEDICAL COLL OF CORNELL UNIV2022–2026
  • Engineering islet-like organoids from gastric stem cells for T1D cell replacement therapyWEILL MEDICAL COLL OF CORNELL UNIV2022–2026
  • Engineering islet-like organoids from gastric stem cells for T1D cell replacement therapyWEILL MEDICAL COLL OF CORNELL UNIV2022–2026
  • Engineering islet-like organoids from gastric stem cells for T1D cell replacement therapyWEILL MEDICAL COLL OF CORNELL UNIV2022–2026
  • Derivation of pancreatic islet-like organoids from human gastric stem cellsWEILL MEDICAL COLL OF CORNELL UNIV2022–2026
  • Engineering islet-like organoids from gastric stem cells for T1D cell replacement therapyWEILL MEDICAL COLL OF CORNELL UNIV2022–2026
  • Derivation of pancreatic islet-like organoids from human gastric stem cellsWEILL MEDICAL COLL OF CORNELL UNIV2022–2026
  • Derivation of pancreatic islet-like organoids from human gastric stem cellsWEILL MEDICAL COLL OF CORNELL UNIV2022–2026
  • Engineering islet-like organoids from gastric stem cells for T1D cell replacement therapyWEILL MEDICAL COLL OF CORNELL UNIV2022–2026
  • Engineering islet-like organoids from gastric stem cells for T1D cell replacement therapyWEILL MEDICAL COLL OF CORNELL UNIV2022–2026
  • Negative feedback regulation of growth factor signaling in adult spermatogonial stem cellsWEILL MEDICAL COLL OF CORNELL UNIV2021–2026
  • Methods for detection of dynamic intracellular signals in single adult spermatogonial stem cellsWEILL MEDICAL COLL OF CORNELL UNIV2023–2025
  • Investigating a master regulator of large intestine stem cellsWEILL MEDICAL COLL OF CORNELL UNIV2021–2025
  • Investigating a master regulator of large intestine stem cellsWEILL MEDICAL COLL OF CORNELL UNIV2021–2025
  • Investigating a master regulator of large intestine stem cellsWEILL MEDICAL COLL OF CORNELL UNIV2021–2025
  • Investigating a master regulator of large intestine stem cellsWEILL MEDICAL COLL OF CORNELL UNIV2021–2025
  • Investigating a master regulator of large intestine stem cellsWEILL MEDICAL COLL OF CORNELL UNIV2021–2025
  • Investigating a master regulator of large intestine stem cellsWEILL MEDICAL COLL OF CORNELL UNIV2021–2025
  • Endothelial cell transplantation for multi-organ repair to counter radiation injuryWEILL MEDICAL COLL OF CORNELL UNIV2018–2025
  • Endothelial cell transplantation for multi-organ repair to counter radiation injuryWEILL MEDICAL COLL OF CORNELL UNIV2018–2025
  • Identification Of Vascular Inductive Signals In Liver RegenerationNational Institute Of Diabetes And Digestive And Kidney Diseases2012
  • Contribution Of The Vascular Niche To The Hematopoietic Reconstitution.National Heart, Lung, And Blood Institute2009–2011
  • Contribution Of Cxcr4+Vegfr1+ Hemangiogenic Progenitors To Lung RevascularizationNational Heart, Lung, And Blood Institute2007–2011
  • Dynamic Regulation Of The Epigenome During Hematopoietic DifferntiationNational Heart, Lung, And Blood Institute2009–2010
  • Reconstitution Of Thrombopoiesis By Angiogenic FactorsNational Institute Of Allergy And Infectious Diseases2009
  • Therapy Of Thrombocytopenic Disorders By ChemokinesNational Heart, Lung, And Blood Institute2006–2007
  • Vascular Heterogeneity Determination By Marrow Progenit*National Heart, Lung, And Blood Institute2004–2006
  • Regulation Of Hemangiogenesis By Adenoviral E4 GenesNational Heart, Lung, And Blood Institute2002–2006
  • Postnatal Angiogenesis And Marrow Derived Precursor CellNational Heart, Lung, And Blood Institute2001–2005
  • Vascular Heterogeneity Determination /Marrow ProgenitorsNational Heart, Lung, And Blood Institute2003
  • Bone Marrow Totipotent Stem Cells &Adenoviral VectorsNational Heart, Lung, And Blood Institute2000–2002
  • Chemokine Receptors And ITP And HIV ThrombocytopeNational Heart, Lung, And Blood Institute1998–2002
  • Endothelium Regulation Of Stem Cell Homing/ProliferationNational Heart, Lung, And Blood Institute1997–2000
  • Regulation Of Thrombopoiesis By Bone Marrow EndotheliumNational Heart, Lung, And Blood Institute1994–1996

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: